IRCT20231121060132N1
Recruiting
Phase 3
Investigating the effectiveness of famotidine as a radioprotector in reducing the mucosal and hematological complications of prostate cancer radiotherapy
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Kermanshah University of Medical Sciences
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients aged 30 to 75 with prostate cancer candidates for radiotherapy
- •Do not receive PPI drugs and other H2 antagonist drugs
Exclusion Criteria
- •Lack of consent to participate in the study
- •Patients with kidney disease that cannot be prescribed famotidine
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
The effectiveness of adding famotidine and vitamin B6 to standard drug treatment in patients with schizophrenia disorderIRCT20150822023705N16Kermanshah University of Medical Sciences80
Completed
Phase 1
Evaluation of the Radioprotective Effect of Famotidine Against Radiotherapy- induced Acute Toxicity in Patients with Prostate CancerProstate CancerBowel toxicityUrinary toxicityCancer - ProstateOral and Gastrointestinal - Normal oral and gastrointestinal development and functionRenal and Urogenital - Normal development and function of male and female renal and urogenital systemACTRN12612000101886School of Paramedical Sciences, Shahid Beheshti Medical University,36
Recruiting
Not Applicable
Bioequivalence study of Famotidine SuspensioIn the present study, the products will be administered to healthy volunteers.IRCT20210519051345N44Tabriz University of Medical Sciences24
Completed
Phase 3
Clinical trial on the effectiveness of the Famotidine on symptoms of schizophrenic patientsIRCT20190707044123N1Rasht University of Medical Sciences64
Recruiting
Phase 3
Famotidine and COVID-19aboratory confirmed COVID-19.COVID-19, virus identifiedU07.1IRCT20200509047364N2Bandare-abbas University of Medical Sciences20